Manage Your Liver
Q:

Why do some people like me with fatty liver develop inflammation (NASH), while some do not? Is it possible to get rid of the inflammation?

A:

There are two types of fatty liver disease, alcoholic and nonalcoholic. Usually, inflammation caused by alcoholic fatty liver disease will go away once the patient ceases alcohol intake. The situation is different for nonalcoholic fatty liver disease (NAFLD). NAFLD is characterized by the accumulation of fat in the liver, it is a spectrum of diseases that ranges from mild to severe. Although having fat in the liver is not normal, simple fatty liver generally does not cause great harm. In addition, many people with fatty liver do not have any symptoms and have normal liver function. [1] 

 

However, when the buildup of fat in the liver causes inflammation in liver cells, liver health may be threatened. This situation is known as nonalcoholic steatohepatitis (NASH), a more severe form of NAFLD. NASH is characterized by buildup of fat in the liver, along with inflammation and liver damage. The ALT level of NASH patients are usually more elevated than those with fatty liver.

 

The exact cause of NASH is not yet known. It occurs more frequently in middle-aged and overweight or obese people. The number of female with NASH is also higher than male. Many NASH patients also have certain medical conditions such as diabetes, high blood cholesterol or triglyceride and insulin resistance. But there are also some who do not have diabetes, are not obese and have normal blood lipids. [2] Thus, at the moment, it cannot be concluded that these are the factors that lead to inflammation in the liver.

 

Medical professionals generally advise NASH patients to reduce weight (if overweight), control their diet and increase physical exercise to treat NASH. Besides lifestyle changes, research papers on PubMed show that a compound made from natural ingredients, YHK, has positive effects on NASH patients. [3][4] It has been proven that YHK has anti-inflammatory effects and can restore normal liver function. A double-blind clinical study of the compound also indicates that the ALT levels of patients lowered to normal level within 2 weeks of using YHK. [5]

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Fatty Liver DiseaseAlcoholic fatty liver diseaseNonalcoholic SteatohepatitisYHKYHK Therapy
Related Questions
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us